Corleen M. Roche is CFO at IOVANCE BIOTHERAPEUTICS, INC. (IOVA). They have made 1 open-market trade across 1 company since 2024, most recently 2026-08-06.
CIK 0001857905
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $38K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CGON | BUY | 2024-01-29 | 2024-01-31 | $19.00 | $38K | +17.8% | +18.4% | +8.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.